Acute pancreatitis associated with high-dose interleukin-2 immunotherapy for malignant melanoma.
作者信息
Birchfield G R, Ward J H, Redman B G, Flaherty L, Samlowski W E
机构信息
Division of Hematology/Oncology, University of Utah School of Medicine, Salt Lake City.
出版信息
West J Med. 1990 Jun;152(6):714-6.
Abstract
摘要
相似文献
1
Acute pancreatitis associated with high-dose interleukin-2 immunotherapy for malignant melanoma.高剂量白细胞介素-2免疫疗法治疗恶性黑色素瘤相关的急性胰腺炎。
West J Med. 1990 Jun;152(6):714-6.
2
[Acute pancreatitis after high-dose interferon therapy in a patient with melanoma].
Presse Med. 2001 Jun 30;30(22):1105.
3
Syndrome of inappropriate antidiuretic hormone secretion caused by high-dose bolus interleukin-2 therapy for metastatic melanoma.高剂量白介素-2 冲击疗法治疗转移性黑色素瘤导致抗利尿激素分泌不当综合征。
Am J Ther. 2011 Sep;18(5):e159-61. doi: 10.1097/MJT.0b013e3181cec222.
4
Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.皮下注射粒细胞巨噬细胞集落刺激因子、低剂量白细胞介素2和干扰素α联合免疫疗法用于进展期转移性黑色素瘤和肾细胞癌的I期试验
Clin Cancer Res. 2000 Apr;6(4):1267-72.
5
Malignant melanoma therapy by chemotherapy and autoimmunity induced by cytokine.通过化疗和细胞因子诱导的自身免疫进行恶性黑色素瘤治疗。
Cancer Biother Radiopharm. 2009 Apr;24(2):237-41. doi: 10.1089/cbr.2008.0552.
6
Immunotherapy-induced leukoderma from treatment of melanoma with IL-2: a case report and a review of the literature.白介素-2治疗黑色素瘤引发的免疫疗法诱导性白斑病：一例病例报告及文献综述
Acta Derm Venereol. 2015 Feb;95(2):197-200. doi: 10.2340/00015555-1897.
7
Should high-dose interleukin-2 still be the preferred treatment for patients with metastatic melanoma?高剂量白细胞介素-2 仍应是转移性黑色素瘤患者的首选治疗方法吗？
Cancer Biother Radiopharm. 2012 Aug;27(6):337-43. doi: 10.1089/cbr.2012.1220.
8
Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy.黑色素瘤患者中的白癜风：正常组织抗原可成为癌症免疫治疗的靶点。
J Immunother Emphasis Tumor Immunol. 1996 Jan;19(1):81-4.
9
Activity of continuous infusion plus pulse interleukin-2 with famotidine in patients with metastatic kidney cancer or melanoma previously treated with interleukin-2.连续输注加脉冲式白细胞介素-2联合法莫替丁在先前接受过白细胞介素-2治疗的转移性肾癌或黑色素瘤患者中的活性。
Cancer Biother Radiopharm. 2006 Oct;21(5):437-42. doi: 10.1089/cbr.2006.21.437.
10
Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma.黑色素瘤或肾细胞癌患者序贯低剂量5-氮杂-2'-脱氧胞苷加高剂量静脉推注白细胞介素-2的I期试验。
Clin Cancer Res. 2006 Aug 1;12(15):4619-27. doi: 10.1158/1078-0432.CCR-06-0883.
引用本文的文献
1
High-dose interleukin-2 therapy related adverse events and implications on imaging.大剂量白细胞介素-2 治疗相关不良反应及其对影像学的影响。
Diagn Interv Radiol. 2021 Sep;27(5):684-689. doi: 10.5152/dir.2021.20503.
2
Ever-increasing diversity of drug-induced pancreatitis.药物性胰腺炎的多样性不断增加。
World J Gastroenterol. 2020 Jun 14;26(22):2902-2915. doi: 10.3748/wjg.v26.i22.2902.
3
Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.药物性胰腺炎：病例报告的系统回顾，以确定潜在的药物关联性。
PLoS One. 2020 Apr 17;15(4):e0231883. doi: 10.1371/journal.pone.0231883. eCollection 2020.
4
Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.白细胞介素-2。其药理学特性及在癌症患者中的治疗应用综述。
Drugs. 1993 Sep;46(3):446-514. doi: 10.2165/00003495-199346030-00009.
5
Clinical toxicity of interleukin-2.白细胞介素-2的临床毒性
Drug Saf. 1992 Nov-Dec;7(6):417-33. doi: 10.2165/00002018-199207060-00004.
本文引用的文献
1
Drug-induced pancreatitis: a critical review.药物性胰腺炎：一项批判性综述。
Gastroenterology. 1980 Apr;78(4):813-20.
2
Interleukin 2.白细胞介素2
Annu Rev Immunol. 1984;2:319-33. doi: 10.1146/annurev.iy.02.040184.001535.
3
Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.对转移性癌症患者进行自体淋巴因子激活的杀伤细胞和重组白细胞介素-2全身给药的观察。
N Engl J Med. 1985 Dec 5;313(23):1485-92. doi: 10.1056/NEJM198512053132327.
4
Acute pancreatitis.急性胰腺炎。
Ann Intern Med. 1985 Jul;103(1):86-100. doi: 10.7326/0003-4819-103-1-86.
5
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.关于使用淋巴因子激活的杀伤细胞和白细胞介素-2或单独使用高剂量白细胞介素-2治疗157例晚期癌症患者的进展报告。
N Engl J Med. 1987 Apr 9;316(15):889-97. doi: 10.1056/NEJM198704093161501.
6
Clinical effects and toxicity of interleukin-2 in patients with cancer.白细胞介素-2对癌症患者的临床疗效及毒性
Cancer. 1986 Dec 15;58(12):2764-72. doi: 10.1002/1097-0142(19861215)58:12<2764::aid-cncr2820581235>3.0.co;2-z.
7
NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.美国国立卫生研究院会议。使用白细胞介素-2进行癌症免疫治疗的新方法。
Ann Intern Med. 1988 Jun;108(6):853-64. doi: 10.7326/0003-4819-108-6-853.
8
Acute pancreatitis.
Surg Clin North Am. 1988 Apr;68(2):281-99. doi: 10.1016/s0039-6109(16)44478-6.
9
Colonic perforation. An unusual complication of therapy with high-dose interleukin-2.结肠穿孔。高剂量白细胞介素-2治疗的一种罕见并发症。
Cancer. 1988 Dec 1;62(11):2350-3. doi: 10.1002/1097-0142(19881201)62:11<2350::aid-cncr2820621116>3.0.co;2-s.
Zotero 插件